[Platelet antiaggregants in the treatment of vasculopathies].
A complete and vast study about platelet antiaggregants, alone or associated to other drugs, is presented. Studying firstly these drugs, and afterwards its clinical use: cerebral ischemia, myocardium acute infarct, angor pectoris, revascularization coronary surgery, coronary percutaneous transluminal angioplasty, valvular prosthesis, valvulopathies, vascular prosthetic grafts, and others.
Honorato
J
J
Centro de Investigación en Farmacobiología Aplicada, Universidad de Navarra, Pamplona, España.
Montes-Jovellar
B
B
D015906:Angioplasty, Balloon, Coronary; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D006350:Heart Valve Prosthesis; D006801:Humans; D009204:Myocardial Revascularization; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000517:prevention & control; D013927:Thrombosis / Q000517:prevention & control
D010975:Platelet Aggregation Inhibitors
Antiagregantes plaquetarios en el tratamiento de vasculopatías.